Compare IMVT & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | VFC |
|---|---|---|
| Founded | 2018 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.6B |
| IPO Year | 2019 | 1994 |
| Metric | IMVT | VFC |
|---|---|---|
| Price | $28.57 | $19.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 18 |
| Target Price | ★ $33.00 | $18.24 |
| AVG Volume (30 Days) | 1.5M | ★ 6.3M |
| Earning Date | 05-28-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.72 |
| EPS | N/A | ★ 0.95 |
| Revenue | N/A | ★ $10,488,556,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.06 |
| P/E Ratio | ★ N/A | $20.37 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.52 | $11.11 |
| 52 Week High | $30.09 | $22.27 |
| Indicator | IMVT | VFC |
|---|---|---|
| Relative Strength Index (RSI) | 59.62 | 53.40 |
| Support Level | $22.25 | $18.06 |
| Resistance Level | $29.67 | $20.40 |
| Average True Range (ATR) | 1.28 | 0.82 |
| MACD | -0.04 | -0.19 |
| Stochastic Oscillator | 63.57 | 28.95 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.